432. Solankee Sejal; Prajapati Yogesh; Patel Hiral; Solankee Pankit; PatelGhyanshayam; Kapadia Kishor; Solankee Anjani. Department of Chemistry,B.K.M. Science College, Valsad, India. Acta Ciencia Indica, Chemistry 2008,34(1), 121-125.433. Patel, Hiral; Prajapati, Yogesh; Solankee, Pankit; Solankee, Sejal; Patel,Ghanshyam; Kapadia, Kishor; Solankee, Anjani. Department of Chemistry,B.K.M. Science College, Valsad, India. Acta Ciencia Indica, Chemistry 2008 ,34(2), 145-149.434. G. D. Diana and C. P. Michel ; S. African ZA 1981, 81 03, 105 ; Chem. Abstr.,1983, 98, 16671.435. Vi- Ping Tao ; Eur. Pat. Appl. Ep 57550 ( Cl C 07 D 261/14) 1982 ; Chem. Abstr.,1983, 98, 16672.436. Hass Duane K and Carr John B. ; US 1982, 3 , 879, 532 (Cl 424-272 A 61K) ;Chem. Abstr., 1975, 83, 108627h.437. T. Tochiro, K. Shrji, M. Hiroshi, S. Akira and V. Hiroshi ; Ger. Offen DE 1983, 3, 237,149 ( Cl. CO7 A 261/14) ; Chem. Abstr., 1984, 99, 88188.438. Nippon Chemiphar Co. Ltd. Jpn. ; Kokai Tokkyo koho JP 1983, 58, 46, 077 (83,46, 077) ( Cl. CO7 A 261/14) ; Chem. Abstr., 1984, 99, 17574.439. J. T. Strupczewski, R. C. Allen and R. W. Dunn ; J. Med. Chem., 1985, 28, 761 ;Chem. Abstr. 1985, 102, 203897v.440. R. Maior, B. Eisele, P. Multer and H. Grube ; Ger. Offen. DE 3621372 (1998) ;Chem. Abstr., 1988, 108, 67456f.441. B. Victor, J. Safir and Sidney R. (American Cyanamid Co.) ; Brit. 1970, 1, 178069(Cl C 07 D) ; Chem. Abstr.,1970, 72, 79017d.442. C. P. Alfred and C. S. Mary ; Eur. Pat. Appl. EP 560, 483 (Cl. C 07 D 261/08), USAppl. 850035 ; Chem. Abstr., 1994, 120, 134453e.443. M. D. Mackie, H. S. Anthony, W. J. R. Howe ; S. P. John and W. S. Marry ; Brit. UKPat. Appl. GB 2, 265, 371 ( Cl C 07 D 261/06) ; Chem Abstr., 1994, 120, 1641532.444. M. Scobie and M. D. Threadojill ; J. Org. Chem., 1994, 59, 7008 ; Chem. Abstr.,1995, 122, 559344.445. S. Rung and D. Dus Pharmazie 1994, 49, 727 ; Chem. Abstr., 1995, 122, 559344.446. A. Ando and R. W. Stevens ; PCT Int. Appl. WO 94, 12, 481 (Cl C 07 D 261/04)Chem. Abstr., 1995, 122, 56037x.184References…..
447. G.P. Reddy, E. Rajendra and A. K. Murthy ; Indian J. Heterocycl., 1995, 122,160522e.448. A. K. Banerjee et al ; Arzneim Forsch., 1994, 44, 863. Chem. Abstr., 1995, 122,160522n449. M. Scobie and M. D. Theeadujill ; J. Org. Chem, 1994, 59, 7008 ; Chem.Abstr.1995, 122, 10090f.450. A. K. Banerjee et. al. ; Arzneim Forsch, 1994, 44, 863 ; Chem. Abstr., 1995, 122,160522n.451. A. Ando and R. W. Stevens ; PCT. Int. Appl. WO, 94, 12, 481, ( Cl C 07 D 261/04) ;Chem. Abstr., 1995, 122, 56037x.452. G. P. Reddy, E. Rajandra and A. K. Murthy ; Indian J. Heterocycl., 1994, 3, 233 ;Chem. Abstr., 1995, 122, 165724e453. S. Rang and D. Dns ; Pharmazic, 1994, 49, 727 ; Chem. Abstr., 1995, 122,559344f.454. B. C. Hamper et. al ; J. Agri. Food. Chem., 1995, 43, 219 ; Chem. Abstr., 1995,122, 49000c.455. M. D. Mackie, H. S. Anthony, W. J. R. Howe, S. P. John and W. S. Marry ; Brit : UK.Pat. Appl. G. B. 2, 265, 371, (Cl. C07D 261/06) ; Chem. Abstr., 1994, 120, 164152.456. C. P. Alfred and C. S. Marg ; Eur. Pat. Appl. Ep 560, 483 (Cl. C07D 261/08), USAppl. 850035 ; Chem. Abstr., 1994, 120, 134453e.457. Rajeev Jain, D. D. Agrawal and Damodharan ; J. Ind. Chem. Soc., 1995, 72, 825-827.458. Inai, Masatoshi, Tanaka, Akie, Goto, Kyoto ; Jpn Kokai Tokkyo Koho JP 07, 215,952 (95, 215, 952) (1995) ; J. P. Appl. 1993, 93, 1304, 921, 19 pp ; Chem. Abstr.,1996, 124, 86995(s).459. Akhil H. Bhatt, H. H. Parekh and A. R. Parikh ; J. of hetero. Communication 1998,4, 4.460. Masui Mloriyasu ; Hasegawa, Yasushi ; Chem. Abstr., 1998, 128, 13256z.461. Reddy Kusukuntla Venkat ; Sabitha G. ; Rao A. V. Subba ; Indian J. Chem. Sec. B ;Org. Chem., Ind. Med. Chem. 1998, 37B(7), 677-699.462. Nyitrai Jozsef ; Nagy Jozsef ; Simig Gyula et.al. ; Chem. Abstr., 1998, 129,260397p.185References…..
- Page 3:
The Sarvodaya Education Society’s
- Page 6 and 7:
selfless help, moral support and gu
- Page 9 and 10:
Introduction and Spectral studies .
- Page 11 and 12:
“STUDIES ON SOME HETEROCYCLICENTI
- Page 13 and 14:
Pyrimidine derivatives have been pr
- Page 15 and 16:
Isoxazole derivative synthesized by
- Page 17 and 18:
“STUDIES ON SOMEHETEROCYCLIC ENTI
- Page 19 and 20:
(b) Pharmacokinetics: It is derived
- Page 21 and 22:
(C) Drug DevelopmentMany natural pr
- Page 23 and 24:
The process of drug design is exten
- Page 25 and 26:
(l) Non steroidal anti-inflammatory
- Page 27 and 28:
INTRODUCTIONThe aza-indolizine cont
- Page 29 and 30:
PHARMACEUTICAL IMPORTANTMuch resear
- Page 31 and 32:
Compd. R 1 R 2 R 3a :- H 7-Me-6,8-B
- Page 33 and 34:
S. Kristjan, Gudmundsson and A. Bra
- Page 35 and 36:
STUDIES ON IMIDAZOPYRIDINE DERIVATI
- Page 37 and 38:
(a) Chalcones with monoethanolamine
- Page 39 and 40:
Das B.P. et al. 111 have found that
- Page 41 and 42:
Furthermore, Alcaraz M.J, et al. 13
- Page 43 and 44:
REACTION SCHEMECl+ClOClOClClCH 3NH
- Page 45 and 46:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 47 and 48:
SignalNo.SignalPosition(δppm)Relat
- Page 49 and 50:
ANTIMICROBIAL ACTIVITYProducts : Ch
- Page 51 and 52:
The reaction mixture was poured on
- Page 53 and 54:
TABLE NO.- 1A BIOLOGICAL SCREENING
- Page 55 and 56:
PART-IISTUDIES ON PYRIMIDINES
- Page 57 and 58:
The self consistent (pi)electron de
- Page 59 and 60:
class of dye viz. trichloro pyrimid
- Page 61 and 62:
ability to cleave nucleic acid targ
- Page 63 and 64:
SSNHNHoONOoONOo(11) (12)oOHThe Pyri
- Page 65 and 66:
called ABPP or bropirimine(2-amino-
- Page 67 and 68:
acid so that it could be utilized f
- Page 69 and 70:
have reported the 5-substitutedfuro
- Page 71 and 72:
maturation of the viral mRNA molecu
- Page 73 and 74:
Nevertheless, these compounds const
- Page 75 and 76:
OHHNCH 3Cl(CH 2 )nSNNR 2R 1N H 2NSR
- Page 77 and 78:
SECTION-ISTUDIES ONOXOPYRIMIDINES
- Page 79 and 80:
PHARMACEUTICAL IMPORTANCEIn recent
- Page 81 and 82:
REACTION SCHEMECH 3NNCHOCl10% KOH R
- Page 83 and 84:
INSTRUMENT :SHIMADZU FTIR 8400 Spec
- Page 85 and 86:
SignalNo.SignalPosition(δppm)Relat
- Page 87 and 88:
EXPERIMENTALSynthesis and therapeut
- Page 89 and 90:
TABLE NO.- 2(IB)PHYSICAL CONSTANTS
- Page 91 and 92:
INTRODUCTIONThiopyrimidine derivati
- Page 93 and 94:
H 3 COHNRH 3 CH 3 CNHS( IV ) R = ar
- Page 95 and 96:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 97 and 98:
IR SPECTRAL STUDIES OF 6-(2-(4-CHLO
- Page 99 and 100:
NMR SPECTRAL STUDIES OF 6-(2-(4-CHL
- Page 101 and 102:
MASS SPECTRAL STUDIES OF 6-(2-(4-CH
- Page 103 and 104:
[F] Antimicrobial activity of 6-(2-
- Page 105 and 106:
SECTION-IIISTUDIES ONAMINOPYRIMIDIN
- Page 107 and 108:
ArCHO+ArCOCH3NaOHMethanolR R 1ONaOH
- Page 109 and 110:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 111 and 112:
IR SPECTRAL STUDIES OF 4-(2-(4-CHLO
- Page 113 and 114:
NMR SPECTRAL STUDIES OF 4-(2-(4-CHL
- Page 115 and 116:
MASS SPECTRAL STUDIES OF 4-(2-(4-CH
- Page 117 and 118:
[F] Antimicrobial activity of 4-(2-
- Page 119 and 120:
PART-IIISTUDIES ONCYCLOHEXENONES
- Page 121 and 122:
2. Michael addition of chalcone wit
- Page 123 and 124:
Rheinheimer J. et al. 381have synth
- Page 125 and 126:
SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 127 and 128:
IR SPECTRAL STUDIES OF ETHYL-6-(2-(
- Page 129 and 130:
NMR SPECTRAL STUDIES OF ETHYL-6-(2-
- Page 131 and 132:
MASS SPECTRAL STUDIES OF ETHYL-6-(2
- Page 133 and 134:
Antimicrobial testing was carried o
- Page 135 and 136:
PART-IVSTUDIES ON PYRAZOLINES
- Page 137 and 138:
H 2 C= CHCN + Ar - NHNH 2NArN(3) 2
- Page 139 and 140:
PHARMACEUTICAL IMPORTANCE :2- Pyraz
- Page 141 and 142:
Kadu et al. 424 and antimicrobial b
- Page 143 and 144:
REACTION SCHEMECH 3NNClCHO10% KOHRO
- Page 145 and 146:
Instrument : SHIMADZU FTIR 8400 Spe
- Page 147 and 148:
SignalNo.SignalPosition(δppm)Relat
- Page 149 and 150:
EXPERIMENTALSynthesis and therapeut
- Page 151 and 152:
TABLE NO.- 4(B)PHYSICAL CONSTANTS O
- Page 153 and 154:
INTRODUCTION:Isoxazole come under t
- Page 155 and 156: PHARMACEUTICAL IMPORTANCE :Isoxazol
- Page 157 and 158: SYNTHESISAND THERAPEUTIC EVALUATION
- Page 159 and 160: IR SPECTRAL STUDIES OF 2-(4-CHLOROP
- Page 161 and 162: NMR SPECTRAL STUDIES OF 2-(4-CHLORO
- Page 163 and 164: MASS SPECTRAL STUDIES OF 2-(4-CHLOR
- Page 165 and 166: [F]Antimicrobial activity of 2-(4-c
- Page 167 and 168: PART-VISTUDIES ON OXIRANES
- Page 169 and 170: ( iii ) Epoxidation can also been c
- Page 171 and 172: Moreover, Nomura Yutaka et al. 487
- Page 173 and 174: SYNTHESIS AND THERAPEUTIC EVALUATIO
- Page 175 and 176: IR SPECTRAL STUDIES OF (3-(2-(4-CHL
- Page 177 and 178: NMR SPECTRAL STUDIES OF (3-(2-(4-CH
- Page 179 and 180: MASS SPECTRAL STUDIES OF (3-(2-(4-C
- Page 181 and 182: [F] Antimicrobial activity of (3-(2
- Page 184 and 185: 1. J. A. Joule and K. Mills; Hetero
- Page 186 and 187: 37. James J. Kaminski, D. G. perkin
- Page 188 and 189: 78. Ms. B. S. Hastak and B. J. Ghiy
- Page 190 and 191: 116. V. R. Mudalir and V. Joshi ; I
- Page 192 and 193: 150. S. Inoue, A. J. Saggimoto and
- Page 194 and 195: 197. S. S. Bahekar, D. B. Shinde; A
- Page 196 and 197: 238. A. Kreutzberger and M. Sellhei
- Page 198 and 199: 280. See, for example, W. H. Prusof
- Page 200 and 201: 326. C. W. Whitehead and J. J. Trav
- Page 202 and 203: 366. Nagarjan K., Shenoy S. J.; Ind
- Page 204 and 205: 396. Ausra Voskiene,Vytautas Mickev
- Page 208 and 209: 463. Mishra Ashutosh ; Jain Sanmati
- Page 210 and 211: 496. Kaneko Mashami, Saitoh Yutaka,
- Page 212 and 213: CH 3CH 3NNClNNClORHNONRRRC 6 H 5 -
- Page 214 and 215: CH 3CH 3NNClNNClEtOOCORHNNRRRC 6 H